Skip to content
Secnidazole
Solosec (secnidazole) is a small molecule pharmaceutical. Secnidazole was first approved as Solosec on 2017-09-15. It is used to treat bacterial vaginosis in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
urogenital diseasesD000091642
Trade Name
FDA
EMA
Solosec
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Secnidazole
Tradename
Company
Number
Date
Products
SOLOSECLupin ResearchN-209363 RX2017-09-15
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
solosecNew Drug Application2021-01-08
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
bacterial vaginosisEFO_0003932D016585
Agency Specific
FDA
EMA
Expiration
Code
SECNIDAZOLE, SOLOSEC, LUPIN
2027-09-15GAIN
2025-01-26NPP
2024-06-30I-866
2022-09-15NCE
Patent Expiration
Patent
Expires
Flag
FDA Information
Secnidazole, Solosec, Lupin
103353902035-09-04DPU-2583, U-3270
106823382035-09-04DPU-2583, U-3270
108498842035-09-04DPU-2583, U-3169, U-3270, U-3302
108571332035-09-04DPU-2583, U-3270
110005072035-09-04DPU-2583, U-3169, U-3270, U-3302
110005082035-09-04DPU-2583, U-3169, U-3270, U-3302
110203772035-09-04DPU-2583, U-3169, U-3270, U-3302
113247212035-09-04DPU-2583, U-3169, U-3270, U-3302
116025222035-09-04DPU-3169, U-3302
ATC Codes
J: Antiinfectives for systemic use
J01: Antibacterials for systemic use
J01R: Combinations of antibacterials
J01RA: Combinations of antibacterials
J01RA07: Azithromycin, fluconazole and secnidazole
P: Antiparasitic products, insecticides and repellents
P01: Antiprotozoals
P01A: Agents against amoebiasis and other protozoal diseases
P01AB: Nitroimidazole derivatives, antiprotozoal agents against amoebiasis and other protozoal diseases
P01AB07: Secnidazole
HCPCS
No data
Clinical
Clinical Trials
361 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Covid-19D000086382U07.14115
Chronic hepatitis bD019694EFO_0004197B18.111114
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LeukemiaD007938C958317246
LymphomaD008223C85.98314143
MelanomaD0085458293139
Breast neoplasmsD001943EFO_0003869C501720233
NeuroblastomaD009447EFO_00006215135223
Myelodysplastic syndromesD009190D468131122
Plasma cell neoplasmsD054219512117
Hiv infectionsD015658EFO_0000764B20812415
Pancreatic neoplasmsD010190EFO_0003860C2537110
SarcomaD0125092529
Show 15 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C8071621
Prostatic neoplasmsD011471C6171116
Lung neoplasmsD008175C34.906814
Ovarian neoplasmsD010051EFO_0003893C566712
Colorectal neoplasmsD01517941011
Myeloid leukemia acuteD015470C92.0379
Multiple myelomaD009101C90.03519
Central nervous system neoplasmsD016543369
Kidney neoplasmsD007680EFO_0003865C64378
Fallopian tube neoplasmsD005185437
Show 64 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Parkinson diseaseD010300EFO_0002508G2033
Colonic neoplasmsD003110C1822
Rectal neoplasmsD01200422
Kaposi sarcomaD012514C4622
GliomaD005910EFO_000052022
AstrocytomaD001254EFO_000027122
OligodendrogliomaD009837EFO_000063122
Hepatocellular carcinomaD006528C22.022
Small cell lung carcinomaD05575211
Plasma cell leukemiaD007952C90.111
Show 30 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Residual neoplasmD01836511
Peripheral arterial diseaseD058729EFO_000426511
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSECNIDAZOLE
INNsecnidazole
Description
Secnidazole is a C-nitro compound that is 5-nitroimidazole in which the hydrogens at positions 1 and 2 are replaced by 2-hydroxypropyl and methyl groups, respectively. It has a role as an epitope. It is a C-nitro compound, a member of imidazoles and a secondary alcohol.
Classification
Small molecule
Drug classantiprotozoal substances (metronidazole type)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Cc1ncc([N+](=O)[O-])n1CC(C)O
Identifiers
PDB
CAS-ID3366-95-8
RxCUI36314
ChEMBL IDCHEMBL498847
ChEBI ID
PubChem CID71815
DrugBankDB12834
UNII IDR3459K699K (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 511 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
1,524 adverse events reported
View more details